Capvizr
News · All summaries
Healthcare & Life Sciences
One Biosciences
Series AUndisclosed
RoundSeries A
AmountUndisclosed
LeadGalion
HQParis, France
DateSeptember 11, 2026
THE DEAL, AT A GLANCE

One Biosciences

From the announcement
Who is involvedBacked by Galion, France 2030From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
What happenedOne Biosciences raised Series A, announced 2026-09-11From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Why it mattersOne Biosciences' $3.3M Series A is a small Healthcare & Life Sciences financing for single-cell diagnostics, positioned at the 7th percentile of tracked sector round…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

One Biosciences · Financing Record

Explore source-linked visual explanations for One Biosciences. Unsupported claims are withheld while source review continues.

Record 12158 · Recorded date: 2026-09-11

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime